Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes

In a previous part of this study, we created educational modules about the psychodermatology of inflammatory skin conditions, with a particular emphasis on atopic dermatitis, for patients. These modules will empower patients to better manage both the psychological and physical aspects of their skin conditions. As part of this project, we aim to conduct a clinical trial to determine the effectiveness of these modules on eczema severity and health-related quality of life in patients. We hope to use these findings to develop and disseminate accessible educational material on the psychological aspects of dermatologic care.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Atopic Dermatitis (AD) Congenital, Hereditary, and Neonatal Diseases and Abnormalities Dermatitis Dermatitis, Atopic Genetic Diseases, Inborn Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Skin Diseases Skin Diseases, Eczematous Skin Diseases, Genetic Skin and Connective Tissue Diseases

Age range

4 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kaye Edmonton Clinic, Edmonton, Alberta, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

New diagnosis or follow-up for previous diagnosis of Atopic Dermatitis.
Reliable internet access to be able to access the e-modules.
Able to speak English at a level required to understand the content of this study.
Child participants will be included in this study contingent on the consent of their guardian/caregiver(s).
Age range of eligible participants: Age 4 years and older.

Exclusion criteria

Does not have a new diagnosis or follow-up for previous diagnosis of Atopic Dermatitis.
Unable to access and/or navigate e-modules with reasonable support/instruction.
Unable to speak English at a level required to understand the content of this study.
Unable to provide informed consent.
Less than 4 years of age.

Treatment and study plan

Patient education modules providing information on the psychological aspects of atopic dermatitis treatment and management.

Behavioral

Provision of online patient educational modules (in addition to patients receiving regular clinical action/ appointments at the Kaye Edmonton Clinic, the Stollery Children's Hospital, and the Rao Dermatology Clinic for Atopic Dermatitis).

Primary outcomes

Health-Related Quality of Life

Time frame: Baseline, 4 weeks, and 12 weeks

Quality of Life will be measured using the Dermatology Life Quality Index (DLQI). The scores range from 0 to 30 (higher score indicative of worse outcomes)

Secondary outcomes

Eczema Disease Severity

Time frame: Baseline, 4 weeks, and 12 weeks

Eczema Disease Severity will be measures using the Patient-Oriented SCORing for Atopic Dermatitis (PO-SCORAD). Scores range between 0 and 103 points (higher score indicative of worse outcomes)

Sponsors and collaborators

Lead sponsor

University of Alberta

Other

Registry information

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Jun 6, 2025
Registry last updated: Aug 27, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting